Plain language summary and patient perspective of the ASCO guideline: management of Stage III NSCLC
Future Oncology, our partner journal, has recently published a Plain Language Summary of Publication and patient perspective of the ASCO guidelines on the management of Stage III NSCLC.
Read the Plain Language Summary here
Abstract
What is this summary about?
This is a plain language summary of a guideline on the management of Stage III NSCLC. This guideline was written by the American Society for Clinical Oncology (ASCO) and published in the Journal of Clinical Oncology.
Why were the guidelines developed?
The purpose of the ASCO guideline is to provide recommendations to healthcare professionals in the US including oncologists, surgeons, pathologists, radiologists, and nurses on how best to diagnose and treat people with stage 3 NSCLC.
How were the guidelines developed?
The ASCO guideline is based on the latest research and scientific evidence to make certain the recommendations are up to date and based on reliable data and best practice. In 2021, a group of experts were asked by ASCO to form an Expert Panel. The Expert Panel reviewed the results of 127 clinical research studies on NSCLC that were done between 1990 and 2021. They looked at how NSCLC had been diagnosed and treated in these studies, as well as at patients’ survival and quality of life. The Expert Panel used these findings and their own expertise to form their recommendations and produce the 2021 ASCO Guideline called ‘Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline’.
What information does the guideline contain?
The guideline aims to answer the following questions:
- What are the most precise ways to confirm and stage NSCLC in people suspected of having a stage 3 disease?
- Which patients with Stage III NSCLC can be treated most successfully with surgery?
- Which patients who can be treated with surgery could also have an additional therapy before their surgery?
- Which patients who can be treated with surgery could also have an additional treatment after their surgery?
- Which treatment and/or management is most suitable for patients who cannot have surgery?
